Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
PMV Pharmaceuticals, Inc
University of Chicago
Tubulis GmbH
Eli Lilly and Company
Merus B.V.
M.D. Anderson Cancer Center
University of Arizona
Betta Pharmaceuticals Co., Ltd.
Theravectys S.A.
Kidney Cancer Research Bureau
Perspective Therapeutics
Second Life Therapeutics
Onchilles Pharma Inc
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Kura Oncology, Inc.